Avrobio Inc reported $-32620000 in EBIT for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Akebia Therapeutics AKBA:US $ -54886000 24.46M
Alnylam Pharmaceuticals ALNY:US $ -181677000 35.52M
Applied Genetic Technologies AGTC:US $ -16003000 2.62M
Bluebird Bio BLUE:US $ -196779000 44.06M
Epizyme EPZM:US $ -64140000 5.91M
Gilead Sciences GILD:US $ 3883M 1637M
Intercept Pharmaceuticals ICPT:US $ -6218000 6.73M
Karyopharm Therapeutics KPTI:US $ -43812000 5.24M
Macrogenics MGNX:US $ -52987000 12.71M
Pfizer PFE:US $ 9254M 2592M
Sangamo Biosciences SGMO:US $ -48436000 264K
Sarepta Therapeutics SRPT:US $ -34458000 133.12M
Takeda 4502:JP 97.43B 151.12B